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Summary
The crystal structure of human retinitis pigmentosa 2
protein (RP2) was solved to 2.1 A˚ resolution. It con-
sists of an N-terminal b helix and a C-terminal ferre-
doxin-like a/b domain. RP2 is functionally and struc-
turally related to the tubulin-specific chaperone
cofactor C. Seven of nine known RP2 missense muta-
tions identified in patients are located in the b helix do-
main, and most of them cluster to the hydrophobic
core and are likely to destabilize the protein. Two res-
idues, Glu138 and the catalytically important Arg118,
are solvent-exposed and form a salt bridge, indicating
that Glu138 might be critical for positioning Arg118 for
catalysis. RP2 is a specific effector protein of Arl3. The
N-terminal 34 residues and b helix domain of RP2 are
required for this interaction. The abilitities of RP2 to
bind Arl3 and cause retinitis pigmentosa seem to be
correlated, since both the R118H and E138G mutants
show a drastically reduced affinity to Arl3.
Introduction
Retinitis pigmentosa (RP) comprises a large group of
heterogeneous diseases that results in progressive ret-
inal degeneration and is the leading cause of hereditary
blindness in humans. The prevalence of RP within the
population is 1:3000–1:5000 (Haim, 2002). Mutations in
more than 30 genes are known to cause RP (RetNet:
http://www.sph.uth.tmc.edu/Retnet/home.htm). Most
of the proteins encoded by these genes are involved in
photoreception and transduction, but genes encoding
transcription factors, and proteins involved in protein
folding and trafficking, are also affected (Farrar et al.,
2002). RP with an X-linked hereditary pattern causes
the most severe forms of the disease. Approximately
10%–15% of the X-linked RP cases are caused by
mutations in the retinitis pigmentosa 2 protein (RP2)
(Schwahn et al., 1998; Hardcastle et al., 1999). RP2 en-
codes a protein of 350 residues and is ubiquitously ex-
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delberg, Germany.pressed in all tissues at a low level (Schwahn et al.,
1998; Chapple et al., 2000). It is both myristoylated and
palmitoylated at the N terminus and is located at the
plasma membrane. A deletion of Ser6 in RP2, which is
known to cause RP, interferes with the targeting of the
protein to the plasma membrane (Chapple et al., 2000).
The function of RP2 is still not well understood. It is
a functional and structural homolog of the tubulin-spe-
cific chaperone cofactor C, and it has a sequence iden-
tity of 30.4% over a range of 151 amino acids (RP2 res-
idues 42–192) (Schwahn et al., 1998). Cofactors A–E
participate in tubulin folding. After the release of newly
synthesized a- and b-tubulin subunits from the the cyto-
solic chaperonin TRIC/CCT, a- and b-tubulin folding in-
termediates form a complex with cofactors C, D, and
E. Cofactors C and D together stimulate GTP hydrolysis
by b-tubulin. The GTPase activating protein (GAP) activ-
ity of cofactors C and D is further enhanced by cofactor
E. GTP hydrolysis triggers the release of the native tubu-
lin heterodimer from the supercomplex (Tian et al., 1995,
1996, 1997, 1999). Together with cofactor D, RP2 also
stimulates the GTPase activity of b-tubulin, but, unlike
cofactor C, RP2 cannot substitute for cofactor C in the
tubulin heterodimer assembly pathway (Bartolini et al.,
2002). A conserved arginine in cofactor C has been pos-
tulated to act as an arginine-finger in the GTP hydrolysis
of tubulin, analogous to the arginine-finger in RasGAP
(Scheffzek et al., 1997). The R262A mutation in cofactor
C abolishes its GAP activity. This arginine is conserved
in RP2 (Arg118), and the mutation of Arg118 to His found
in RP patients (Schwahn et al., 1998; Sharon et al., 2000)
results in a protein with no GAP activity (Bartolini et al.,
2002).
The GTP binding proteins Arl2 and Arl3 (Arf-like) are
closely related members of the Arf (ADP ribosylation
factor) subfamily of the Ras-related protein superfamily.
Arl2 was identified in S. cerevisae as a chromosome in-
stability mutant, Cin4 (Hoyt et al., 1990). A homolog of
Arl2 in C. elegans, evl-20, associates with microtubules
and was proposed to regulate cytoskeletal dynamics
during cytokinesis and morphogenesis (Antoshechkin
and Han, 2002); mutations of this gene in Arabidopsis
thaliana disrupt microtubules (Mayer et al., 1999). Arl2
interacts with cofactor D (Shern et al., 2003; Bhamidipati
et al., 2000), and it was shown that Arl2 downregulates
the tubulin GAP activities of cofactors C, D, and E (Bha-
midipati et al., 2000), but does not bind RP2 (Bartolini
et al., 2002). Arl3, on the other hand, binds to RP2 in
an apparent GTP-dependent manner, and it does not in-
teract with cofactor C (Bartolini et al., 2002). Myristoyla-
tion of RP2 weakens the binding of Arl3 to RP2, leading
to the proposal that Arl3 might bind unmodified RP2
in vivo and facilitate its targeting for modification (Barto-
lini et al., 2002).
Arl3 is localized to microtubule structures throughout
the retina and is present at high concentration in the
connecting cilium of photoreceptors. The connecting
cilium is a thin bridge connecting the cell body and the
outer segment of photoreceptors and plays an impor-
tant role in the trafficking of proteins from the inner to
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is located at the plasma membrane throughout the pho-
toreceptor cells and is not enriched in any photorecep-
tor organelle (Grayson et al., 2002). In analogy to the
role of Arf proteins in cellular transport reactions, Arl3
and RP2 might be involved in protein trafficking in gen-
eral or photoreceptor maintenance in particular.
Additional connections between retinal degeneration
and Arl proteins have been documented. Mutations in
Arl6 cause the Bardet-Biedl syndrome, which is charac-
terized by severe symptoms including blindness and
obesity. TheC. elegans Arl6 homolog is expressed in cil-
iated cells and undergoes intraflagellar transport (Fan
et al., 2004). Both Arl2 and Arl3 interact with the d subunit
of rod-specific cyclic GMP phosphodiesterase (PDEd),
which has been implicated in transport and membrane
targeting of prenylated proteins toward the outer seg-
ments of rod and cones (Linari et al., 1999a). PDEd was
also shown to bind to retinitis pigmentosa GTPase reg-
ulator (RPGR), whose gene, RP3 (Meindl et al., 1996;
Roepman et al., 1996), causes another X-linked form of
the disease (Linari et al., 1999b). RPGR is targeted to
the connecting cilium by the RPGR-interacting protein
(RPGRIP) (Zhao et al., 2003).
Here, we report the crystal structure of human RP2.
The interactions between RP2 and Arl3 were quantita-
tively characterized with purified proteins. RP2 is
a bona fide effector of Arl3. The N-terminal 34 residues
and b helix domain of RP2 are required for binding of
Arl3. The RP2 patient mutations R118H and E138G
show a drastically reduced affinity toward Arl3, indicat-
ing that failure of RP2 to bind Arl3 seems to cause retini-
tis pigmentosa.
Results
The N-Terminal b Helix Domain
The crystal structure of human retinitis pigmentosa 2
protein (RP2) was solved to 2.1 A˚. The phasing was
done with the multiwavelength anomalous diffraction
(MAD) technique with selenomethionine-substituted
protein crystals (Table 1). The model comprises 312 res-
idues, but the N-terminal 33 residues are not visible in
the electron density. The protein consists of an N-termi-
nal b helix domain (1–228) and a C-terminal ferredoxin-
like a/b domain (229–350) (Figure 1A). The parallel b helix
domain is right-handed and consists of seven coils. It
has the overall shape of a rectangular barrel with a diam-
eter of approximately 10 A˚3 20 A˚ and a height of roughly
30 A˚. The first six coils are regular and consist of three
short strands, a, b, and c, each of which forms a parallel
b sheet with the corresponding strands from the other
coils (Figures 1A and 1C). According to the nomencla-
ture first introduced for pectate lyase (Yoder et al.,
1993) and its adaptation for the C-terminal domain of
the cyclase-associated protein (C-CAP) structure (Do-
datko et al., 2004), these sheets are denoted as PB1,
PB1a, and PB2. Strands a and c are 4–6 residues long,
and strand b consists of two amino acids. The first 6
coils contain 19 residues on average, and 2 adjacent
coils are separated by 4.7 A˚, corresponding to an aver-
age b helix rise of 0.25 A˚ per residue. The first six coils
of the b helix superimpose onto each other with an
rmsd of 1.0 A˚ when the variable regions are omitted.The RP2 b helix domain is similar to that of S. cerevi-
siae C-CAP (Dodatko et al., 2004). Despite the low se-
quence identity of 11% between the C-CAP (368–508)
and RP2 b helix domains (34–191), the structures super-
impose with an rmsd of 2.1 A˚ (Figure 1B). Both proteins
differ in their oligomerization states. C-CAP forms
a strand-exchanged dimer, whereas RP2 is monomeric.
Quite unlike other b helix proteins, coils 6 and 7 of RP2
are connected by a very long loop (146–173) that covers
almost one complete face of the b helix domain. This
loop region contains a short helix, an0 (154–161), which
contacts b helix coils 2 and 3. The b helix coil 7 is irreg-
ular and does not contain strand b, and the residues
connecting a and c are disordered. Sequence compari-
son (Figure 2A) shows that, relative to RP2, cofactor C
has a 3 residue insertion in this loop. But, since strands
a and c participate in sheets PB1 and PB2, coil 7 is con-
sidered to be part of the b helix domain.
The extensive main chain hydrogen bond network
within the three b sheets causes the stacked arrange-
ment of the side chains (Figure 1D), both on the surface
and within the core of the b helix. The core of this domain
is tightly packed and mainly hydrophobic. There is no
hydrophobic pocket that could fit a farnesyl or geranyl
moiety as in the Arl2/3 effector PDEd (Hanzal-Bayer
et al., 2002). Only one water molecule is buried in the
core of the b helix domain. This water is located between
coils 2 and 3. It is stabilized by hydrogen bonds, which
are formed with the carbonyl oxygen of Asp76 and the
hydroxyl side chain of Ser78.
At right angles to the long axis of the b helix, the PB1
and PB2 side chains of each coil point toward each other
and are involved in forming the hydrophobic core, as
Table 1. Crystallographic Data Collection and Refinement Statistics
Data Collection
Space group P3221
Cell dimensions
a, b, c (A˚) 81.3, 81.3, 106.1
a, b, g (º) 90, 90, 120
Peak Inflection
Wavelength (A˚) 0.97923 0.97980
Resolution (A˚) 20.0–2.10
(2.16–2.10)
20.0–2.10
(2.16–2.10)
Rsym (%) 4.5 (21.6) 5.0 (27.4)
I/s(I) 21.1 (6.9) 18.7 (5.9)
Completeness (%) 97.9 (88.7) 98.6 (97.4)
Redundancy 5.7 (5.6) 5.8 (5.7)
Phasing
Se sites 4
FOM (acentric/centric) 0.510/0.271
Refinement
Number of reflections 24,149
Rwork/Rfree (%) 19.7/23.5
Number of atoms
Protein 2,399
Water 144
B factors (A˚2)
Protein 32.2
Water 36.1
Rms deviations
Bond lengths (A˚) 0.016
Bond angles (º) 1.49
Data in parentheses correspond to the highest-resolution bin.
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(A) Ribbon diagram of RP2, with green b strands, red a helices, and gray loop regions. In the N-terminal b helix domain, strands a, b, and c form
the parallel b sheets PB1, PB1a, and PB2. The C-terminal a/b domain has a ferredoxin-like fold. The model includes residues 34–347.
(B) Ca chain traces of the superimposed b helix domains from RP2 (red) and C-CAP (blue).
(C) Details of the b helix fold. A horizontal cross-section of RP2 around coil 3 shows a rectangular shape of the b helix; hydrophobic and hydro-
philic interactions stabilize the fold. Asp85 and Asn88 both adopt a left-handed a-helical conformation. The final 2Fo 2 Fc electron density is
shown (contour level s = 1.0).
(D) Vertical (along the helical axis) cross-section of the b helix domain, showing strands b and c and the corresponding sheets PB1a and PB2,
respectively. Side chains inside the core and residues pointing toward the solvent are stacked in a ladder-like fashion.shown for coil 3 (Figure 1C). Along the axis of the b
helix, there are stacks of hydrophobic, mostly aliphatic
side chains, which include residues Phe42-Ile64-Ile83-
Phe102-Val119-Ile137 in PB1 and Val50-Ile72-Ile91-
Cys110-Val127-Phe145 in PB2 (Figure 1D), where
Phe42 points toward Val50 and Ile64 faces Ile72, etc.
The two other ladders include residues Phe62-Val81-
Val100-Phe117-Pro135 in PB1 and Ile74-Leu93-Leu112-
Leu129 in PB2. In addition, there are two ladders within
the core of the b helix consisting of weakly hydrophobic/
hydrophilic side chains, with a high incidence of cyste-
ines: Leu45-Cys67-Cys86-Cys105-Cys122-Ser140 are
the first residues of strand b. Glu48-Cys70-Cys89-
Cys108-Leu125-Ile143 form the second hydrophilic lad-der and correspond to the first residues of strand c. The
interactions of the side chains of these hydrophilic resi-
dues appear to be important for the stabilization of the
b helix.
Strands a/b and b/c of the b helix domain are sepa-
rated by 1 residue, and only 3 residues are required to
make turns of roughly 90º (Figure 1C). The amino acids
connecting these strands adopt a left-handed a-helical
conformation, and their side chains point toward the sol-
vent. The tight turn between strands a and b is stabilized
by a weak hydrogen bond formed between the thiol
group of the first residue of strand b, denoted as i, (or
the hydroxyl side chain in the case of Ser140 in coil 6)
and the main chain carbonyl oxygen of residue i22.
Structure
370Figure 2. Sequence Conservation between the N-Terminal b Helix Domain of RP2 and the C-Terminal Domain of Cofactor C
(A) Alignment of amino acid sequences of human RP2 (O75695, Swiss-Prot), mouse RP2 (Q9EPK2, TrEMBL), rat RP2 (XM_346266, NCBI), Xe-
nopus RP2 (BC04122, NCBI), and cofactor C of human (Q15814, Swiss-Prot), chimpanzee (XM_518477, NCBI), dog (XM_538923, NCBI), and
chicken (XM_426123, NCBI) are shown. Conserved residues are highlighted, with the degree of conservation decreasing from dark green to yel-
low. Sequence alignment was done with ClustalW (Higgins et al., 1996), and analysis of the degree of conservation was done with AMAS (Living-
stone and Barton, 1993). Missense mutations identified in retinitis pigmentosa patients are marked with an asterisk. The catalytically important
residue Arg118 is labeled in red.
(B) Surface representation of the b helix domain with surface residues of the b helix domain color coded according to their degree of conservation
as in (A); the front side is on the left, and the less-conserved back side is on the right. The position of Arg118 is marked with a red asterisk. The
backbone of the C-terminal domain is shown in blue.The formation of hydrogen bonds between the side
chain of residue i and the carbonyl oxygens of i22 has
been previously observed in the C-CAP structure (Do-
datko et al., 2004). The exception is the a/b turn in RP2
coil 1, where Leu45 occupies position i and shields the
core of the b helix domain from the solvent. Leu45 is in-
capable of forming a stabilizing hydrogen bond. Gly44 is
located at position i21, and, as a consequence, this turn
might be less strained compared to other turns, where
a nonglycine amino acid has to adopt the left-handed
a-helical conformation; thus, additional stabilization
through a hydrogen bond is not necessarily required.
In contrast to the C-CAP structure, additional hydrogen
bonds are observed in three of the b/c turns of RP2. The
thiol group of residue i+3, the first residue of strand c,forms a weak hydrogen bond with the main chain car-
bonyl oxygen of the second residue in strand b (i+1).
The cysteine residues at positions i and i+3 would, in
principle, be capable of forming disulfide bridges with
each other, but no disulfide bridges are visible in the
electron density.
The b helix domains of RP2 and cofactor C share a se-
quence identity of 30%. The conservation of the sur-
faces of the two proteins is highest in the region sur-
rounding Arg118 and on the more C-terminal part of
the b helix domain, arguing that this is the site of func-
tional interactions (Figure 2B). Both proteins show less
similarity in the N-terminal part and the side of the do-
main opposite of Arg118. This degree of conservation
in the region of the catalytically important Arg118 further
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nal RP2 Domain and NDP Kinase
(A) Superimposition of Ca chain traces of the
C-terminal RP2 domain (red, residues 229–
347) andDictyosteliumNDP kinase (blue, res-
idues 6–155, PDB code: 1hiy) with bound
30deoxy-30amino-ADP (black) is shown. The
transiently phosphorylated His122 in NDP ki-
nase is replaced by Phe325 in RP2; the side
chain of Asp287 of RP2 would clash with
the sugar moiety of ADP.
(B) Structure-based sequence alignment be-
tween the C-terminal RP2 domain and NDP
kinase. The catalytically important residue
His122 of NDP kinase is labeled with a red as-
terisk. Secondary structure elements of both
structures are shown, and identical residues
are marked. Superimposition and sequence
alignment were done with DaliLite (Holm
and Park, 2000).supports the idea of one common functional role of RP2
and cofactor C.
The C-Terminal Ferredoxin-like a/b Domain
The C-terminal a/b domain (229–350) has a ferredoxin-
like fold (Figure 3). It forms a three-layered a+b sandwich
with an antiparallel b sheet with the strand order of bc2-
bc3-bc1-bc4 in the sheet, and it is surrounded by 4 a he-
lices and a short 310 helix on both sides. A DALI search
(Holm and Sander, 1993) showed that the C-terminal do-
main is structurally very similar to nucleoside diphos-
phate (NDP) kinase (Figure 3A). The C-terminal b strands
and a helices 1, 3, and 4 of RP2 superimpose with an
rmsd of 2.2 A˚ onto the Dictyostelium NDP kinase (PDB
code: 1npk). A structure-based sequence alignment of
RP2 and NDP kinase is shown in Figure 3B. The se-
quence identity between both domains is 22%. NDP ki-
nase catalyzes the phosphorylation of nucleoside di-
phosphates to triphosphates. The reaction involves a
two-step phosphotransfer reaction with a covalent in-
termediate in which the active site residue His122 is
phosphorylated. Despite the general structural similarity
of NDP kinase and the RP2 C-terminal domain, there are
significant differences around the NDP kinase active
site, since residues required for NDP kinase activity
are not conserved in RP2. The transiently phosphory-
lated residue His122 is replaced by Phe325 in RP2. No
other histidines are present in the neighborhood of
Phe325. Asp287 of RP2 would clash with the sugar moi-
ety of the bound nucleotide from NDP kinase. No bound
ligands are visible in the RP2 electron density. Further-
more, no binding of ADP to RP2 could be detected by
isothermal calorimetry (data not shown). This result
and the large differences between the active site ofNDP kinase and the corresponding residues in the C-
terminal domain of RP2 indicate that RP2 should have
no NDP kinase-like phosphotransferase activity. The
function of the C-terminal domain thus remains unde-
fined.
The Catalytically Active Arg118
Arg118 in coil 5 in the b helix domain is solvent accessi-
ble (Figures 4A and 4B). It is conserved throughout dif-
ferent species in both RP2 and cofactor C, and the
neighboring hydrophobic residues Phe177, Ile136, and
Phe101 are also conserved (Figure 2A). Next to Arg118
in coil 5 are the conserved Gln116 and Arg120. Arg120
is conserved in RP2, but it is replaced by a histidine in
cofactor C. The unconserved Arg103 is the second argi-
nine in the proximity of Arg118. Two conformations of
Arg118 are visible in the electron density. The guanidi-
nium group of Arg118 of the major conformer (60% oc-
cupancy) forms a hydrogen bond with two waters, one
of which forms hydrogen bonds with the side chain of
Thr133, and the carbonyl oxygen of Gln134. An acidic
residue close enough to Arg118 to form a salt bridge is
Glu138. In the major conformer, the side chain of
Arg118 points away from Glu138, while the second con-
former forms a salt bridge with Glu138 (distance 3.4 A˚).
The proposal that Glu138 has an important functional
role, such as to position Arg118 for catalysis, is strength-
ened by the observation that Glu138 is mutated in retini-
tis pigmentosa (see below). In the crystal, the salt bridge
forming conformation is less occupied (40% occu-
pancy), most likely due to the close proximity of
Leu313 of a symmetry-related molecule; there is a dis-
tance of 3.4 A˚ between the methyl group of Leu313
and the guanidinium group of Arg118.
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(A) Stereoview of the Ca backbone of RP2; every tenth Ca atom is labeled. Side chains of residues mutated in RP patients and corresponding
missense mutations are included.
(B) Localization and interaction of Arg118, a residue essential for the GAP activity of the tubulin cofactor C, and RP2, which is frequently mutated
in RP. Hydrogen bonds between the arginine side chain and nearby waters are shown. The second lower occupied conformation of Arg118 is
shown in light blue and forms a salt bridge with Glu138, which is also mutated in RP.RP2 Mutations
Many of the mutations identified in retinitis pigmentosa
patients are insertions and deletions, which result in
frameshifts and/or premature truncation of the protein,
with a loss of function of RP2 in the affected individuals
(Breuer et al., 2002; Mears et al., 1999; Miano et al.,
2001). The most prevalent mutation is a point mutation
yielding a premature termination at Arg120 (Mears
et al., 1999; Vorster et al., 2004). A deletion of three
bases, 409–411, retains the reading frame but causes
a deletion of Ile137 (Sharon et al., 2000). This residue is
located in strand 6a, and its deletion likely destabilizes
the b helix domain.
Missense mutations are known for nine amino acids
and are shown in Figure 4A. Some of them cluster to
the hydrophobic core and would be expected to desta-
bilize the protein. Seven of the affected amino acids are
located in the b helix domain. Mutations of Cys67 and
Cys86, the first residues of strand b in coils 2 and 3, re-
spectively, to the aromatic tyrosine (Breuer et al., 2002;
Sharon et al., 2000) disturbs the tight hydrophobic
core packing around these cysteines, and it may addi-
tionally destabilize the core due to the loss of a (albeit
weak) hydrogen bond between the thiol side chain and
the carbonyl oxygen of residue i22. Creation of a cavity
by the C108G mutation (Mears et al., 1999) inside the
tightly packed hydrophobic core of the b helix domain
is presumably also destabilizing. This mutant is furtherdestabilized because, unlike the thiol side chain, glycine
cannot form a hydrogen bond with the carbonyl oxygen
of the second residue of strand b. Pro95 is highly con-
served in RP2 and cofactor C. It is situated in a tight
turn, which is stabilized by a hydrogen bond between
the carbonyl oxygen of Gly94 and the amide nitrogen
of Val96. The P95L mutation (Sharon et al., 2000) would
cause clashes with Phe159 in helix an0 and the side
chain of Leu164 (both residues are conserved in RP2
of different species).
The side chain of Leu188, conserved in RP2, is in van
der Waals contact with Trp171 and Trp186 and favorably
interacts with the hydrophobic part of the Arg228 side
chain. The L188P mutation (Breuer et al., 2002) probably
destabilizes the loop (188–192), which connects the last
strand of the b helix domain with the C-terminal domain.
Leu253 is located in helix ac1 of the C-terminal domain. It
is part of the hydrophobic core and interacts with hydro-
phobic side chains from helix ac3 and strands bc1 and
bc3. The mutation of Leu253 to arginine (Wada et al.,
2000) would cause severe clashes in hydrophobic core
packing.
Of particular interest are mutations of surface-ex-
posed residues, because they might be involved in inter-
actions of RP2 with its binding partners (see below). The
R282W mutant, although identified in RP patients
(Miano et al., 2001), has been suggested to be a low-fre-
quency polymorphism (1.7%) rather than a disease
RP2 Structure and Arl3 Interaction
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(A) RP2 is specific for Arl3. A total of 200 mM nucleotide-free Arl2 (black) or Arl3 (red) was added to 1 mM mGppNHp to saturate the nucleotide with
protein. After equilibration, 10 mM RP2 was added, which yields an additional increase in polarization for Arl3, but not for Arl2.
(B) Binding of Arl3 to the N terminus of RP2. A total of 200 mM nucleotide-free Arl3-His protein was added to 1 mM mGppNHp in several steps to
reach saturation. As indicated, 10 mM full-length RP2, N-terminal domain, or C-terminal domain as GST fusion constructs were added. An in-
crease of polarization could only be observed for the full-length protein or the N-terminal domain.variant (Thiselton et al., 2000). It is striking that Arg282 is
the only nonglycine outlier in the Ramachandran plot.
The electron density of this residue is well defined.
Arg282 is located in a tight turn connecting helices
ac310 and ac2 and is stabilized by a complex network
of hydrogen bonds. Since Arg282 is not well conserved
and is replaced by glutamine in mouse, gallus, and
Xenopus, it is apparently not crucial for interactions
with other proteins.
The presumed catalytically important and invariant
residue Arg118 is mutated to Leu, His, Lys, or Cys in
many RP patients (Breuer et al., 2002; Miano et al.,
2001; Schwahn et al., 1998; Bader et al., 2003). Glu138,
which is also conserved between RP2 and cofactor C,
is located in the vicinity of Arg118 and is capable of
forming a salt bridge with Arg118. The E138G mutation
(Miano et al., 2001) should have no detrimental effect
on the overall stability of RP2, but Glu138 might be crit-
ical for positioning Arg118 for catalysis, or it may affect
some other properties of the protein.
Quantitative Evaluation of RP2-Arl3 Binding
In order to relate the structural findings with the bio-
chemistry, we needed to set up a quantitative assay
for the interaction between RP2 and Arl proteins. Bind-
ing of RP2 to Arl was followed by a fluorescence polari-
zation assay. Binding of the fluorescent GTP analog
mGppNHp to the small GTP binding protein Arl3 (21
kDa) leads to an increase of polarization. Further addi-
tion of RP2 (40 kDa) or GST-RP2 (66 kDa) to Arl3-
mGppNHp results in an additional increase of polariza-
tion due to the formation of a higher molecular mass
complex. As a control, we repeated the experiments with
Arl2, which showed an increase in polarization upon
binding to mGppNHp, but no further increase upon ad-
dition of RP2. We could thus confirm previous results
from pull-down experiments that showed that RP2 binds
specifically to Arl3 and not to Arl2 (Bartolini et al., 2002)
(Figure 5A). Although we cannot exclude weak binding
of RP2 to excess Arl3, this binding is specific for the na-
ture of the nucleotide, as no increase in polarization to
Arl3-mGDP could be observed (also see below).To determine the equilibrium binding affinity between
Arl3 and RP2, and to show that RP2 is a bona fide effec-
tor of Arl3, an equilibrium titration was performed by us-
ing a constant concentration of Arl3 bound to mant-nu-
cleotides (excess Arl3, 1 mM nucleotide) and increasing
concentrations of RP2 protein. The increase of polariza-
tion was fitted by a binding equation. The Kd value for
Arl3-mGppNHp and RP2 is 64 nM (Figure 6A). The affin-
ity of RP2 to the GDP bound form of Arl3 is about 400-
fold weaker (Figure 6B), similar to what has been found
for other G protein-effector interactions in which differ-
ences in affinity in the order of 1000-fold were measured
(Rudolph et al., 2001; Rose et al., 2005).
Previously, it has been observed that binding of effec-
tors to GTP binding proteins stabilizes guanine nucleo-
tide binding, and that such GDI (guanine-nucleotide dis-
sociation inhibitor) effects can be used to quantitatively
measure binding affinities (Rudolph et al., 2001). For
RP2, we could also show that it acts as a GDI for the
GTP bound form of Arl3. With increasing amounts of
RP2 in the assay, we observed decreasing dissociation
rate constants of mGppNHp from Arl3 (Figure 6C). The
dissociation rates, kobs, were plotted against the RP2
concentrations. We determined the affinity between
Arl3-mGppNHp and RP2 to 92 nM, which is in the
same range as the value obtained from polarization ex-
periments. The dissociation rate constant of mGppNHp
from Arl3 is 3.53 1024 s21 and is reduced 10-fold (4.43
1025 s21) when Arl3-mGppNHp is saturated with RP2.
Since only mGppNHp bound Arl3 was monitored in the
GDI assay, and the binding affinity is in the same range
as that obtained by the direct equilibrium bind-
ing method, we can exclude that nucleotide-free Arl3
has a measurable binding affinity for RP2 in our assay
conditions.
The N-Terminal Domain Is Sufficient for Arl Binding
It was investigated whether both domains of RP2 are re-
quired for binding of Arl3-GTP. The N- and C-terminal
domains (amino acids 1–230, amino acids 230–350)
were expressed and used as GST fusion proteins, since
they were less stable than the full-length protein. An
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(A and B) A total of 1 mM (A) Arl3-mGppNHp or (B) Arl3-mGDP was titrated with increasing amounts of RP2, and the increase in polarization was
plotted against the RP2 concentration. Data were fitted to a quadratic equation to determine the equilibrium dissociation constants.
(C) Inhibition of the nucleotide dissociation from Arl3 protein by the interaction with RP2. The observed dissociation rates of mGppNHp from Arl3
were plotted against the RP2 concentrations used in the GDI assay. The concentration of Arl3-mGppNHp was 500 nM. The curve was fitted with
a single exponential equation to determine the equilibrium dissociation constant.increase of polarization could be detected only after ad-
dition of the N-terminal domain, but not of the C-terminal
domain (Figure 5B). The smaller increase of polarization
due to the N-terminal domain compared to the full-
length construct is due to the lower molecular mass of
the former. We conclude that Arl3 binds to the part of
RP2 homologous to cofactor C, and that the C-terminal
part is not required for binding.
Since the first 33 N-terminal amino acids of RP2 are
not visible in the structure, the importance of these res-
idues for Arl3 binding was analyzed. A deletion mutant
lacking the first 34 amino acids (RP2 D34) was tested
in the polarization assay and showed an affinity to
Arl3-mGppNHp of 19 mM, roughly 300-times lower than
full-length RP2 (Figure 7A). The CD spectra of full-length
and truncated RP2 show no significant differences
(Figure 7B).
Effect of Patient Mutations on RP2-Arl3 Binding
As deduced from the structure and discussed above,
most of the mutations in RP2 are likely to destabilize
the protein, rather than to influence the biochemistry
of RP2. In contrast, mutations on the surface might influ-
ence interactions with binding partners. R118H was one
of the first RP2 mutations discovered in patients
(Schwahn et al., 1998). We tested the affinity of this
and two other surface mutations, E138G and R282W,
for their interactions with Arl3. Substantiating earlier
qualitative observations (Bartolini et al., 2002), we foundthat R118H reduces the affinity of RP2 for Arl3 by over
800-fold (Figure 7A), with a Kd of 52 mM, which is even
lower than what is found for the interaction of wild-
type RP2 with Arl3-GDP. The E138G mutation decreases
the affinity by 150-fold. This shows that the mutated pro-
teins can no longer bind Arl3 with physiologically rele-
vant affinities. The R282W mutation in the C-terminal do-
main of RP2 is not expected to affect the binding to Arl3
dramatically, since Arl3 does not require this domain for
binding. In keeping with this prediction, the affinity of the
R282W RP2 mutant for Arl3 is reduced only 3-fold com-
pared to wild-type. To exclude that the dramatic effects
on the binding interaction between Arl3 and RP2 are due
to improper folding of the mutant protein, CD spectra of
the wild-type and mutant proteins were recorded (Fig-
ure 7B). All of the mutant proteins show secondary struc-
ture elements similar to the wild-type protein; thus, one
can conclude similar (i.e., proper) folding of the proteins.
Discussion
RP2 is a two-domain protein. The N-terminal b helix do-
main specifically interacts with Arl3, but not Arl2. RP2 is
an effector of Arl3, since the interaction is specific for the
GTP bound state of Arl3. In contrast, the homologous
cofactor C does not bind Arl2, nor does it bind Arl3
(Bartolini et al., 2002). RP2 contains a C-terminal NDP
kinase-like domain, but important catalytic residues
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375Figure 7. N-Terminal Deletion and RP Patient Mutations Affect the RP2-Arl3 Interaction
(A) Affinities of the RP2 mutants R118H, E138G, R282W, or RP2D34 to Arl3 were measured by fluorescence polarization as described for wild-
type in Figure 6A. The measured Kd values for each mutant are shown.
(B) CD spectra of 2.5 mM wild-type and mutant RP2 in 5 mM K2HPO4/KH2PO4 (pH 7.4) at 20ºC.are not conserved in RP2; thus, the biological function of
this domain remains unclear.
The N-terminal 34 residues of RP2 are also required
for Arl3 binding, since their deletion severely weakens
Arl3 binding. The N-terminal residues are not visible in
the electron density because they were degraded during
the 2 months it took the crystals to grow (data not
shown). Secondary structure prediction with JPRED
(Cuff et al., 1998) indicates that the 34 N-terminal resi-
dues are mainly disordered, and only residues 6–9 are
expected to form a short a helix. Preliminary experi-
ments suggest that binding of Arl3 might induce folding
of the N-terminal stretch from RP2. Cofactor C and RP2
show a high degree of conservation in the region encod-
ing the b helix domain, but cofactor C does not share ho-
mology with the N-terminal 34 residues. Instead, the
b helix domain of cofactor C is located at the C terminus,
and cofactor C contains an N-terminal spectrin-like
coiled coil domain, which is expected to interact with
other spectrin repeat-containing proteins (Grynberg
et al., 2003). The specific binding of Arl3 for RP2 as com-
pared to cofactor C thus appears to arise from the 34 N-
terminal residues of RP2 that are absent in cofactor C.
Most of the missense mutations identified in retinitis
pigmentosa patients are expected to have a destabi-
lizing effect on the protein and might interfere with
proper folding. The mutated residues Arg118 and
Glu138 are located on the surface of the b helix domain.
Based on the structure, we propose that Glu138 might
have a role in positioning Arg118 for catalysis. Our affin-
ity measurements also show that Glu138 and Arg118 are
additionally involved in RP2 functioning as an effector
protein for the GTP binding protein Arl3, implying that
the abilities of RP2 to bind Arl3 and cause retinitis pig-
mentosa are correlated. How the function of RP2 in the
folding of the a/b tubulin dimer and its ability to bind
Arl3 are connected needs to be investigated further.
Experimental Procedures
Plasmid Constructs
Cloning of murine Arl2 and Arl3 has been described previously (Re-
nault et al., 2001; Linari et al., 1999a). Arl2 and Arl3 were inserted as
NcoI/XhoI fragments by PCR into the pET20 vector to produce His-
tagged proteins. RP2 constructs (Schwahn et al., 1998) were cloned
as BamHI/EcoRI (RP2 1–350, RP2 230–350 and RP2 D34) or BamHI/XhoI (RP2 1–230) fragments by PCR into pGEX-4T3 to express GST
fusion proteins. The RP2 mutants R118H, E138G, and R282W were
generated by using the QuikChange protocol (Stratagene). RP2
and Arl3 (Q71L) were coexpressed from a bicistronic pGEX-4T-1
plasmid (Amersham Biosciences), in which the N terminus of RP2
was fused to a GST tag between BamHI/EcoRI sites, and the
GTPase-deficient Arl3 (Q71L) mutant was cloned behind RP2 with-
out a tag at the EcoRI site. RP2 contains the D168N mutation, which
is a polymorphism (Lin et al., 2001).
Protein Expression and Purification
Wild-type and mutant RP2 were expressed as GST fusion proteins
from the pGEX-4T3 vector in the E. coli strain Rosetta BL21DE3.
Cell lysate supernatant was applied to a GSH-column (Amersham
Biosciences) preequilibrated with standard buffer (50 mM Tris [pH
7.5], 100 mM NaCl, 5 mM MgCl2, 3 mM b-mercaptoethanol) at 4ºC.
Thrombin (Serva, Heidelberg) cleavage was performed on the col-
umn, and the eluted protein was purified by gel filtration on
a Superdex S75 26/60 column (Amersham Biosciences) with stan-
dard buffer. Purified protein was concentrated, flash-frozen in liquid
nitrogen, and stored at 280ºC.
The truncated RP2 constructs GST-RP2 1–350, 1–230, and 230–
350 were purified as described above by elution from the GSH-col-
umn with standard buffer plus 30 mM glutathione, without the prote-
olysis step. C-terminal His-tagged Arl2 and Arl3 were expressed in
E. coli strain Rosetta BL21DE3. The supernatant of lysed cells was
loaded onto a Ni-NTA column (QIAGEN). Proteins were eluted with
standard buffer with 250 mM imidazol, followed by gel filtration on
a Superdex 75 S26/60 column (standard buffer). To generate nucle-
otide-free Arl proteins, they were incubated with 1 U/mg alkaline
phosphatase (Roche Diagnostics) in an exchange buffer (200 mM
[NH4]2SO4, 1 mM ZnCl2) for 2 hr at 4ºC. Dephosphorylation of nucle-
otides was monitored by HPLC. After dephosphorylation, Arl2/3
were separated from nucleosides and alkaline phosphatase through
Ni-NTA chromatography.
Crystallography
The RP2-Arl3(Q71L) complex was coexpressed from a bicistronic
plasmid. E. coli cells were grown in minimal medium containing se-
lenomethionine as described (Van Duyne et al., 1993). The superna-
tant was loaded onto a GSH-Sepharose column, which was washed
with 20 mM Tris (pH 7.5), 0.3 M NaCl, 5 mM MgCl2, 10 mM DTE and
thereafter treated with thrombin under continuous circulation over-
night at 4ºC. The liberated complex was eluted, concentrated, and
applied onto a Superdex 200 HR16/60 column preequilibrated with
20 mM Tris (pH 7.5), 0.1 M NaCl, 5 mM MgCl2, 10 mM DTE. The eluted
complex was concentrated to 30 mg/ml, frozen, and stored at
280ºC. HPLC analysis showed that the complex was loaded with
GTP. Crystals were grown by the hanging drop method, and 3 ml
35 mg/ml protein solution was mixed with 3 ml of the reservoir solu-
tion (1.8 M [NH4]2SO4, 0.1 M HEPES [pH 7.5]). Crystals grew after 2
months and were found to contain only RP2. Failure to obtain
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376crystals of the complex could have been due to (1) hydrolysis of
GTP, (2) high salt concentration disrupting protein-protein interac-
tions, or (3) degradation of the N terminus of RP2. HPLC analysis
of the 2-month-old crystallization drops showed that the GTP was
completely hydrolyzed, which caused a dissociation of the complex
and thus enabled RP2 to crystallize alone. To investigate the protein
content of the RP2 crystals, they were analyzed on an SDS gel, after
washing with mother liquor and dissolving in water, and showed
a shortened RP2 fragment (not shown) whose exact mass could
not be determined by mass spectrometry. However, since the RP2
model is lacking only the three C-terminal residues, we conclude
that the N terminus of RP2 was degraded. RP2 crystals were flash
cooled in liquid nitrogen after transfer into 20% glycerol, 1.8 M
(NH4)2SO4, 0.1 M HEPES (pH 7.5). Diffraction data were collected
on beamline X06SA at the SLS, Switzerland. Data were processed
with XDS (Kabsch, 1993). The crystals belong to space group
P3221, with unit cell dimensions a = b = 81.5 A˚, c = 105.9 A˚ and
were diffracted to 2.1 A˚. The structure was solved by two-wave-
length MAD phasing with SHARP (de la Fortelle and Bricogne,
1997), automatic model building was done with ArpWarp (Perrakis
et al., 1999), and refinement was carried out with Refmac5 (Mur-
shudov et al., 1999). O was used for inspection of the electron den-
sity maps and manual rebuilding of the model (Jones et al., 1991).
The N-terminal 33 residues, amino acids 181–183, and the C-termi-
nal residues 348–350 are disordered.
Measurement of the Interaction between Arl3-mGppNHp
and RP2
Polarization measurements were performed in a Fluoromax2 spec-
trometer (S.A. Instruments, USA), with excitation at 366 nm and
emission at 450 nm. A total of 1 mM of the fluorescent GTP-analog
mGppNHp (m, mant: N-methylanthraniloyl) was saturated with nu-
cleotide-free Arl proteins until no further increase in polarization
was obtained. For RP2 affinity measurements, increasing amounts
of RP2 proteins were added. The increase in polarization upon addi-
tion of RP2 was integrated over at least 15 min, corresponding to at
least 30 measured values. All measurements were performed in
standard buffer including 0.005% Tween 20 at 10ºC. Data analysis,
fitting, and plotting were done with the Grafit 5.0 program (Erithracus
software, Horley, UK). Kd values were calculated as described else-
where (Kraemer et al., 2001).
The affinity between Arl3-mGppNHp and RP2 was additionally de-
termined by using the inhibition of the nucleotide dissociation from
Arl3 by the binding of the effector RP2. The rate constants (kobs) of
the mGppNHp dissociation from Arl3 were measured in the pres-
ence of varying RP2 concentrations. mGppNHp (500 nM) was incu-
bated in standard buffer with saturating amounts of nucleotide-free
Arl3 and different RP2 concentrations, from 0 to 5 mM at 10ºC. The
reaction was started by adding 1 mM GTP. The fluorescent decay
was monitored in a Fluoromax2 spectrometer (S.A. Instruments,
USA) with excitation and emission at 366 nm and 450 nm, respec-
tively. The fluorescence spectra obtained were fitted by a single ex-
ponential function yielding the rate constant for the mGppNHp dis-
sociation, kobs. The calculated kobs values were plotted against the
concentration of RP2. Kd, k-RP2, and k+RP2 were calculated as de-
scribed before (Herrmann et al., 1996).
Circular Dichroism
The secondary structures of wild-type and mutant proteins were in-
vestigated by circular dichroism. Spectra were recorded from 190
nm to 250 nm on a Jasco J-710 spectrometer (Japan Spectroscopic
Co., Ltd., Tokyo, Japan). Samples were measured in cells of 0.1 cm
path length at 20ºC. Data were collected with 0.5 nm bandwidth, 1 s
time averaging, and a scanning speed of 50 nm/min. A total of 20
spectra were accumulated for each protein.
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